Cat. No. | Product Name | Field of Application | Chemical Structure |
---|---|---|---|
DC1069 | AZD6244 (Selumetinib,ARRY-142886) Featured |
AZD6244 (Selumetinib, ARRY-142886) is highly potent to inhibit MEK1 with IC50 of 14 nM.
More description
|
![]() |
DC9482 | 17-AAG Featured |
17-AAG (17-N-Allylamino-17-demethoxygeldanamycin), also known by its NSC number 330507 and CP number 127374, is a well-studied inhibitor of Heat Shock Protein 90 (HSP90). HSP90 is a molecular chaperone that plays a critical role in the stabilization and activation of a wide range of client proteins, many of which are involved in oncogenic processes. By inhibiting HSP90, 17-AAG disrupts the function of these client proteins, leading to the degradation of oncogenic proteins and ultimately inhibiting cancer cell growth and survival.
More description
|
![]() |
DC4177 | Cobimetinib(GDC-0973; XL518) Featured |
GDC-0973 is a potent, highly selective inhibitor of mitogen-activated protein kinase kinase, also known as MEK, a serine/threonine kinase that is a component of the RAS/RAF/MEK/ERK pathway.
More description
|
![]() |
DC10131 | BMS-986205(Linrodostat) Featured |
BMS-986205 is an optimized indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor, is well tolerated with potent pharmacodynamic activity, alone and in combination with nivolumab in advanced cancers in a phase 1/2a trial
More description
|
![]() |
DC4232 | Vismodegib (GDC-0449) Featured |
Vismodegib (formerly GDC-0449) is a hedgehog antagonist, is also an orally bioavailable small molecule with potential antineoplastic activity.
More description
|
![]() |
DC1099 | Trametinib Featured |
Trametinib is a highly specific and potent MEK1 and MEK2 inhibitor with IC50 of 0.92 nM and 1.8 nM, respectively.
More description
|
![]() |
DC5049 | RAF265 (CHIR-265) Featured |
RAF265 (CHIR-265) is a highly selective B-Raf and VEGFR2 inhibitor with IC50 of 3-60 nM and EC50 of 30 nM, including B-Raf, C-Raf and mutant B-Raf.
More description
|
![]() |
DC6301 | PLX-4720 Featured |
PLX4720 is a potent and selective inhibitor of B-RafV600E with IC50 of 13 nM, equally potent to c-Raf-1(Y340D and Y341D mutations), 10-fold selectivity for B-RafV600E than wild-type B-Raf.
More description
|
![]() |
DC1071 | Vemurafenib (PLX4032) Featured |
PLX4032 (Vemurafenib, RG7204, Zelboraf, RO5185426) is a novel and potent inhibitor of B-RafV600E with IC50 of 31 nM.
More description
|
![]() |
DC8158 | Pexidartinib(PLX3397) Featured |
PLX3397 is a tyrosine kinase inhibitor that potently inhibits the colony stimulating factor 1 (CSF1) receptor kinase, a driving force in the development and growth of PVNS.
More description
|
![]() |
DC8344 | LY3009120 Featured |
LY3009120 is a potent and selective pan-RAF inhibitor with potential anticancer activity.
More description
|
![]() |
DC7868 | AS703026(Pimasertib) Featured |
AS703026(Pimasertib) is a highly selective, potent, ATP non-competitive allosteric inhibitor of MEK1/2 with IC50 of 5 nM-2 μM in MM cell lines.
More description
|
![]() |
DC6901 | Daporinad(FK866,APO866) Featured |
APO866 effectively inhibits nicotinamide phosphoribosyltransferase (NMPRTase) with IC50 of 0.09 nM.
More description
|
![]() |
DC10098 | IDO-IN-1 Featured |
IDO-IN-1 is an indoleamine-2,3-dioxygenase (IDO) inhibitor with IC50 of 59 nM, shows activity in Hela cell (IC50=12 nM).
More description
|
![]() |
DC3102 | GDC-0879 |
GDC-0879 is a novel potent, selective B-Raf inhibitor for B-RafV600E with IC50 of 0.13 nM.
More description
|
![]() |
DC9793 | AMG232 |
AMG232 is a potent, selective and orally bioavailable inhibitor of MDM2−p53 interaction with IC50 value of 9.1 nM in EdU cells .
More description
|
![]() |